Zevia Q2 net sales down 7.2% to $42.2M; net loss narrows to $5.0M

Zevia PBC

2023-Q2 EPS reported -$0.11 revenue$85,541,000

Net sales $42.2M (-7.2% YoY), unit volume down 16.8% to 3.3M cases.
Gross margin 46.6% (+4.2 pp YoY), strongest as a public company.
Net loss $5.0M vs $14.8M YoY; loss per share $0.08.
Adjusted EBITDA loss $2.6M, improved from $6.4M loss a year ago.
Maintains 2023 guidance: net sales $163-168M; Q3 expected $38-41M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Zevia PBC reported second quarter ended June 30, 2023 results: revenue $42.2 million, net income $5.0 million, EPS $0.08 per diluted share. Guidance reaffirmed.

Period: second quarter ended June 30, 2023
Revenue: $42.2 million
Net income: $5.0 million
EPS: $0.08 per diluted share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

simple, plant-based ingredients, today reported results for the second quarter ended June 30, 2023. Second Quarter 2023 Highlights • Net sales decreased 7.2% year over year to $42.2 million • Unit volume decreased 16.8% year over year to 3.3 million equivalized cases • Gross profit margin of 46.6%, up 4.2 percentage points year over year, and the strongest gross

View on SEC.gov

59 earnings releases filed in the last 30 days. Browse all earnings releases →

Zevia PBC filing history →

Source: SEC EDGAR

accession 0000950170-23-039359

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.